SCHEMBL11947294

SCHEMBL11947294

O=C(NCC(=O)N1CCN(c2ccc(OCc3ccccc3)cc2)CC1)c1cccc(OOF)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.57
KDM4E B2RXH2 4/20 0.57
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
KMT2A Q03164 4/20 0.54
MAPK1 P28482 2/20 0.54
USP2 O75604 1/20 0.54
ESR2 Q92731 1/20 0.54
TAAR1 Q96RJ0 1/20 0.54
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
GAA P10253 3/20 0.52
ME2 P23368 1/20 0.46
ME1 P48163 1/20 0.46
ME3 Q16798 1/20 0.46
SMPD1 P17405 1/20 0.46
TSHR P16473 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2309885 0.90 MAPT (0.59) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL12206689 0.90 MAPT (0.59) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL11946893 0.89 GAA (0.63) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL12231799 0.88 MAPT (0.55) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL988322 0.88 MAPT (0.57) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL2312882 0.88 MAPT (0.62) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL2313173 0.87 MAPT (0.56) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL12206697 0.87 MAPT (0.56) MAPTKDM4EALDH1A1LMNANPSR1
Acetic Acid SCHEMBL1042674 0.87 MAPT (0.61) MAPTKDM4EALDH1A1LMNANPSR1
SCHEMBL11024571 0.85 MAPT (0.53) MAPTKDM4EALDH1A1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120189546-A1 Radiolabelling Method Using Cycloalkyl Groups BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120189546-A1 Radiolabelling Method Using Cycloalkyl Groups TMEM14C, PAICS, QPCT MAPT 2575/4885KDM4E 3499/4885ALDH1A1 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.